The operational review occurs while Braskem negotiates an out-of-court debt restructuring agreement—originally filed in August 2026—to address $10.9 billion in gross corporate debt. CFO Carlos Brandão stated that the company, its shareholders, and its creditors are currently exchanging non-binding proposals, though no definitive agreement has been reached ahead of a November 22 deadline. Brandão noted that if a consensus cannot be reached on time, management will evaluate alternative measures to protect stakeholder interests and maintain operations.
Financially, Braskem reported a Q3 net loss of $206 million as global petrochemical spreads normalized following earlier highs, outweighing higher sales volumes. Despite liquidity pressures, Braskem raised its 2026 corporate capital expenditure forecast from $465 million to $496 million under its Operational Excellence 360°
Source: bnamericas